Phreesia, Inc. (NYSE:PHR) Receives Consensus Rating of "Buy" from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have been given a consensus rating of "Buy" by the eleven research firms that are presently covering the company, Marketbeat Ratings reports. Eleven equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $31.64.

A number of equities analysts recently commented on the stock. Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. DA Davidson decreased their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. KeyCorp decreased their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Finally, Truist Financial lifted their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, May 29th.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 1,213 shares of Phreesia stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total value of $28,881.53. Following the completion of the sale, the general counsel owned 137,921 shares of the company's stock, valued at approximately $3,283,899.01. The trade was a 0.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of Phreesia stock in a transaction on Thursday, June 26th. The shares were sold at an average price of $27.67, for a total transaction of $77,531.34. Following the completion of the sale, the director directly owned 22,037 shares of the company's stock, valued at approximately $609,763.79. The trade was a 11.28% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,781 shares of company stock worth $1,504,911. 5.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its stake in shares of Phreesia by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 4,936,515 shares of the company's stock valued at $126,177,000 after purchasing an additional 113,405 shares during the last quarter. Greenhouse Funds LLLP lifted its stake in shares of Phreesia by 2.9% in the 1st quarter. Greenhouse Funds LLLP now owns 2,956,910 shares of the company's stock valued at $75,579,000 after purchasing an additional 83,018 shares during the last quarter. Champlain Investment Partners LLC lifted its stake in shares of Phreesia by 20.0% in the 1st quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company's stock valued at $75,312,000 after purchasing an additional 490,340 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Phreesia by 108.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock valued at $67,606,000 after purchasing an additional 1,377,904 shares during the last quarter. Finally, Franklin Resources Inc. lifted its stake in shares of Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after purchasing an additional 11,986 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Trading Down 6.7%

Phreesia stock traded down $1.93 during midday trading on Thursday, reaching $26.74. The stock had a trading volume of 504,545 shares, compared to its average volume of 455,631. The firm's fifty day simple moving average is $26.34 and its two-hundred day simple moving average is $26.37. Phreesia has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of -36.13 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm had revenue of $115.94 million during the quarter, compared to analyst estimates of $115.00 million. During the same quarter last year, the business posted ($0.05) EPS. The company's revenue was up 14.5% on a year-over-year basis. Equities analysts anticipate that Phreesia will post -1.1 EPS for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.